Back to Journals » Drug Design, Development and Therapy » Volume 11

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Total article views   HTML views PDF downloads Totals
26,330 Dovepress* 18,088+ 1,491 19,579
PubMed Central* 8,242 613 8,855
Totals 26,330 2,104 28,434
*Since 11 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar